Publications Team 2 – INSERM UMR 1033
Bone, Cancers and Metastases
Top 10 publications over the past 5 years
- A. Bellanger, D.T. Le, J. Vendrell, A. Wierinckx, L.S. Pongor, J. Solassol, J. Lachuer, P. Clezardin, B. Gyorffy, P.A. Cohen, Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer, Front Oncol 11 (2021) 647269.
- P. Clezardin, R. Coleman, M. Puppo, P. Ottewell, E. Bonnelye, F. Paycha, C.B. Confavreux, I. Holen, Bone metastasis: mechanisms, therapies, and biomarkers, Physiol Rev 101(3) (2021) 797-855.
- C.B. Confavreux, H. Follet, D. Mitton, J.B. Pialat, P. Clezardin, Fracture Risk Evaluation of Bone Metastases: A Burning Issue, Cancers (Basel) 13(22) (2021).
- C.F. Donini, M. El Helou, A. Wierinckx, B. Gyorffy, S. Aires, A. Escande, S. Croze, P. Clezardin, J. Lachuer, M. Diab-Assaf, S.E. Ghayad, B. Fervers, V. Cavailles, V. Maguer-Satta, P.A. Cohen, Long-Term Exposure of Early-Transformed Human Mammary Cells to Low Doses of Benzo[a]pyrene and/or Bisphenol A Enhances Their Cancerous Phenotype via an AhR/GPR30 Interplay, Front Oncol 10 (2020) 712.
- P. Fahme, F. Ramadan, D.T. Le, K.N. Thi, S.E. Ghayad, N. Hussein, C. Diaz, M. Croset, P. Clezardin, P.A. Cohen, The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression, Cancers (Basel) 14(24) (2022).
- M. Gardegaront, V. Allard, C. Confavreux, F. Bermond, D. Mitton, H. Follet, Variabilities in microQCT-based FEA of a tumoral bone mice model, J Biomech 118 (2021) 110265.
- E. Massy, J.C. Rousseau, M. Gueye, E. Bonnelye, M. Brevet, L. Chambard, M. Duruisseaux, O. Borel, C. Roger, R. Guelminger, J.B. Pialat, E. Gineyts, L. Bouazza, M. Millet, J.M. Maury, P. Clezardin, N. Girard, C.B. Confavreux, Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma, J Bone Oncol 29 (2021) 100364.
- F. Pantano, M. Croset, K. Driouch, N. Bednarz-Knoll, M. Iuliani, G. Ribelli, E. Bonnelye, H. Wikman, S. Geraci, F. Bonin, S. Simonetti, B. Vincenzi, S.S. Hong, S. Sousa, K. Pantel, G. Tonini, D. Santini, P. Clezardin, Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions, Oncogene 40(7) (2021) 1284-1299.
- M. Puppo, M. Jaafar, J.J. Diaz, V. Marcel, P. Clezardin, MiRNAs and snoRNAs in Bone Metastasis: Functional Roles and Clinical Potential, Cancers (Basel) 15(1) (2022).
- [10] F. Ramadan, R. Saab, N. Hussein, P. Clezardin, P.A. Cohen, S.E. Ghayad, Non-coding RNA in rhabdomyosarcoma progression and metastasis, Front Oncol 12 (2022) 971174.
UFR de Médecine Lyon-Est
2ème étage
rue Guillaume Paradin,
69372 Lyon cedex08
France
Phone : +33(0)4 78 77 87 71